No abstract available
Publication types
-
Comment
-
Comparative Study
-
Editorial
MeSH terms
-
Adrenergic beta-Antagonists / therapeutic use
-
Aged
-
Angiotensin II Type 1 Receptor Blockers / therapeutic use*
-
Antihypertensive Agents / therapeutic use*
-
Atenolol / therapeutic use
-
Atrial Fibrillation / mortality
-
Atrial Fibrillation / prevention & control*
-
Cause of Death
-
Double-Blind Method
-
Electrocardiography / drug effects
-
Female
-
Humans
-
Hypertension / drug therapy*
-
Hypertension / mortality
-
Losartan / therapeutic use*
-
Male
-
Middle Aged
-
Myocardial Infarction / mortality
-
Myocardial Infarction / prevention & control
-
Prospective Studies
-
Randomized Controlled Trials as Topic
-
Stroke / mortality
-
Stroke / prevention & control*
-
Survival Rate
Substances
-
Adrenergic beta-Antagonists
-
Angiotensin II Type 1 Receptor Blockers
-
Antihypertensive Agents
-
Atenolol
-
Losartan